Back to top

Eli Lilly & Co: (LLY)

(Delayed quote from NYSE) As of Aug 28, 2014 04:00 PM ET

 Add to portfolio

 ZacksTrade Now

$63.11 USD

63.11

+0.11 (0.18%)

Volume: 2,143,768

Zacks Rank : 3-Hold [?]     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Industry / Sector Report

Industry: LARGE CAP PHARMA

Zacks Industry Rank: 166 / 265 (Bottom 37.36%)

Rank in Industry:

Premium Research: Industry Analysis

Top Peers Symbol Zacks Rank
LILLY ELI & CO LLY
ALLERGAN INC AGN
ABBOTT LABS ABT
ABBVIE INC ABBV
ASTRAZENECA PLC AZN
BAYER A G -ADR BAYRY
BRISTOL-MYERS BMY
H LUNDBECK A S HLUYY
JOHNSON & JOHNS JNJ
MERCK & CO INC MRK

Recommendations and Estimates

Company Industry SP500
Average Recommendation (1=Buy, 5=Sell) 2.29 2.02 9.99
Current Quarter Estimate 0.68 23.11 -999.00
Year Ago Quarter Estimate 1.11 19.58 26.36
Next Quarter Estimate 0.72 22.97 -999.00
Next Year Estimate 3.14 19.00 26.92

Growth Rates

Company Industry SP500
This Year (-32.8) -32.80 0.60 9.00
Next Year (12.5) 12.50 10.50 6.80
Last 5 Years 0.80 4.00 11.20
Next 5 Years 4.80 6.90 NA

Financials

Company Industry
Price/Earnings (TTM) 19.50 34.08
Price/Book (MRQ) 3.92 3.82
Price/Cash Flow (MRFY) 11.93 12.83
Dividend Yield 3.11% 2.61%
Net Profit Margin (TTM) 16.00% 16.59%
Return on Equity (TTM) 19.66% 20.86%
Debt to Equity (MRQ) 0.29 23.54

MRQ = Most Recent Quarter

TTM = Trailing Twelve Months

MRFY = Most Recent Fiscal Year

Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.